SCHEMBL25986754

SCHEMBL25986754

C=CCCC(C(=C)NC)N(C)Cc1cc(CC2CCCC2N)ccc1C=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25992129 0.86 SMN1; SMN2 (0.31) —
SCHEMBL25989012 0.85 SMN1; SMN2 (0.32) —
SCHEMBL26000688 0.85 — —
SCHEMBL25994367 0.83 — —
SCHEMBL26003577 0.82 — —
SCHEMBL25991597 0.81 SMN1; SMN2 (0.32) —
SCHEMBL24692395 0.81 — —
SCHEMBL26025266 0.80 PTGS1 (0.33) —
SCHEMBL25989571 0.79 — —
SCHEMBL25937913 0.79 PRKCI (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820573-B1 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2)-DEPENDENT DISEASES NOVARTIS AG (CH) 2023-08-09 — — EP disclosed
Send feedback